Cite
MLA Citation
LC Coates et al.. “FRI0502 Ixekizumab reduces disease activity in active psoriatic arthritis patients who had previous inadequate response to tumour necrosis factor-inhibitors.” Annals of the rheumatic diseases, vol. 76, n.d., p. 679. http://access.bl.uk/ark:/81055/vdc_100135139165.0x000060